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Summary Major cardio- and cerebrovascular events often occur in individuals without known
preexisting cardiovascular disease. The prevention of such events, including the accurate iden-
tiﬁcation of those at risk, remains a serious public health challenge. Scoring equations to predict
those at increased risk have been developed using cardiovascular risk factors, but they tend
to overestimate the risk in low-risk populations and underestimate it in high-risk populations.
This overview discusses the possible role of ultrasound for an optimized prevention of stroke
and focusses on (1) the importance of embolic signals in asymptomatic carotid stenosis, (2)
the detection of unstable carotid plaques using duplex ultrasonography, and (3) the role of
the ankle—brachial index for the stroke risk prediction in the acute stage and for secondary
prevention.
© 2012 Elsevier GmbH.
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espite the improvements in acute stroke therapy as well
s effective secondary prevention measures, stroke remains
he most important disease for permanent disability and
s the second frequent cause of death worldwide [1]. The
isk factors for stroke are well known and were subdivided
nto non-modiﬁable (e.g. age, sex, genetic predisposition)
nd modiﬁable catergories (e.g. hypertension, smoking, dia-
etes). The INTERSTROKE study [2] shows that 5 risk factors
history of hypertension or blood pressure >160/90mmHg,
moking, waste-to-hip ratio, physical inactivity and diet-risk
core) explain 83.4% of the stroke risk in the population.
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Open access under CC BY-NC-ND license.However, major cardio- and cerebrovascular events often
ccur in individuals without known preexisting cardiovascu-
ar disease. The prevention of such events, including the
ccurate identiﬁcation of those at risk, remains a serious
ublic health challenge [3]. Scoring equations to predict
hose at increased risk have been developed using cardio-
ascular risk factors, but they tend to overestimate the
isk in low-risk populations and underestimate it in high-risk
opulations [4]. An important prerequisite for the use of
urrogate parameters for risk prediction particularly in the
rimary care setting is that these parameters add substantial
ncremental value in risk prediction beyond the traditional
ramingham-type risk scores or give a better estimate to
elect high-risk patients for invasive procedures, e.g. carotid
ndarterectomy (CEA). This overview discusses the possible
ole of ultrasound for an optimized prevention of stroke and
ocusses on (1) the detection of unstable carotid plaques
sing duplex ultrasonography, (2) the importance of embolic
ignals in asymptomatic carotid stenosis (ACS), and (3) the
nd?
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role of the ankle—brachial index for the stroke risk predic-
tion in the acute stage and for secondary prevention.
Detection of embolic signals in asymptomatic
carotid stenosis
Due to the improvements of medical management in
patients with high-grade ACS, there is uncertainty as how
to best manage these patients. New studies demonstrate,
that a well-treated patient with ACS has an annual risk of
ipsilateral stroke of only 0.3% [5]. Therefore, 80 patients
with an ACS must be treated by a CEA to prevent one dis-
abling stroke. Consequently, the cost-effectiveness of CEA
in patients with ACS has been questioned [6]. Nevertheless,
ACS accounts for a large burden of stroke, and the majority
of ipsilateral strokes are unheralded [7]. Identiﬁcation of the
group of ACS patients at higher risk would improve both risk-
beneﬁt and cost-beneﬁt ratios for CEA. Several methods to
identify such a high-risk group have been suggested, includ-
ing ultrasonic detection of asymptomatic embolization. If
clinical embolism is a good predictor of the subsequent
stroke risk, asymptomatic cerebral emboli might also pre-
dict clinical stroke risk [8]. Transcranial Doppler ultrasound
(TCD) is a non-invasive technique that can be used to detect
circulating emboli. Several studies evaluated the associa-
tion between detection of embolic signals and new ischemic
events in patients with ACS [9—11] and reported differ-
ent results. Recently a large prospective and multi-center
study (ACES, Asymptomatic Carotid emboli Study) evaluated
the relationship between asymptomatic emboli and stroke
risk in 467 patients with an ACS of at least 70% [8]. The
detection of emboli was associated with an increased risk
for ipsilateral TIA and stroke (HR 2.54, 95% CI 1.2—5.36)
and in particular for ipsilateral stroke (HR 5.57, 95% CI
1.61—19.32) during 2 years of follow-up even after adjust-
ing for antiplatelet therapy, degree of stenosis, and other
risk factors. The absolute annual risk of ipsilateral stroke
or TIA between baseline and 2 years was 7.13% in patients
with embolic signals and 3.04% in those without, and for
ipsilateral stroke was 3.62% in patients with embolic signals
and 0.70% in those without. The authors performed a meta-
analysis with all studies available including 1144 patients.
The hazard ratio for the risk of ipsilateral stroke for those
with embolic signals compared with those without was 6.63
(95% CI 2.85—15.44) with no heterogeneity between studies
(p = 0.33).
If TCD is to be used as a clinical tool for risk stratiﬁca-
tion, improved methods of automated detection of embolic
signals are needed [8]. TCD recording itself is simple, non-
invasive, and widely used in clinical practice worldwide.
However, review of data for the presence of embolic sig-
nals is time consuming and relies on trained observers.
Automated systems have been developed that have high
sensitivity and speciﬁcity for detecting the higher intensity
embolic signals seen in patients with symptomatic steno-
sis [12]. However, these systems were less sensitive to the
lower intensity embolic signals found in ACS [13]. Therefore
new systems are needed that enable an automatic detec-
tion of emboli even at lower signal intensity levels with an
improved sensitivity and speciﬁcity.
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onclusion
Detection of asymptomatic embolization on TCD can be
used to identify patients with ACS who are at a higher
risk of stroke and TIA.
Assessment of the presence of embolic signals on TCD
might be useful in the selection of patients with ACS who
may beneﬁt from CEA.
Better systems are needed that enable an automatic
detection of emboli even at lower signal intensity levels
with an improved sensitivity and speciﬁcity.
nstable plaque
number of prospective studies have examined associa-
ions between ultrasonic plaque characteristics and stroke
isk in ACS. Associations have been detected with a number
f features including texture heterogeneity, echolucency,
nd surface irregularities [14]. A limited number of studies
ave used a simple measure of echolucency and these have
hown conﬂicting results. More recently, data from ACES
emonstrated that plaque morphology assessed using a sim-
le visual rating scale predicts ipsilateral stroke in ACS [14].
35 subjects with ACS≥ 70% were included and followed-
p for 2 years. A 4-point visual rating scale was applied to
he plaques and they were classiﬁed as echolucent (37.7%)
r echogenic. Plaque echolucency at baseline was associ-
ted with an increased risk of ipsilateral stroke alone (HR
.43, 95% CI 1.36—30.44). A combination of plaque echolu-
ency and ES positivity at baseline was associated with an
ncreased risk of ipsilateral stroke alone (HR 10.61, 95% CI
.98—37.82). The combination of ES detection and plaque
orphology allows a greater prediction than either mea-
ure alone and identiﬁes a high-risk group with an annual
troke risk of 8%, and a low-risk group with a risk of <1% per
ear. These data show that the combination of 2 measures of
laque instability may identify a high-risk group of patients
ith ACS that may beneﬁt from a CEA.
onclusion
Plaque morphology assessed using a simple and clinically
applicable, visual rating scale predicts ipsilateral stroke
risk in ACS.
The combination of asymptomatic emboli detection and
plaquemorphology allows a greater prediction than either
measure alone and identiﬁes a high-risk group with an
annual stroke risk of 8%.
nkle-brachial index (ABI)
eripheral arterial disease (PAD) is increasingly recognized
s a clinically important marker of atherosclerotic disease
ue to its association with cardiovascular disease incidence
nd mortality. Determination of the ABI, which is the ratio
f systolic pressure at the ankle to that in the arm, is quick,
asy to measure and a noninvasive method used to estab-
ish the presence of PAD. The equipment is inexpensive —
handheld Doppler sonograph costs less than 400 EUR. The
rocedure is simple, taking less than 10—15min, and can
102 D. Sander
Table 1 Meta-analysis for the association between an pathological ABI (<0.9) and new vascular events according to [21].
Outcome Age- and sex-adjusted risk
No. of studies Relative risk (95% CI) Test for heterogenicity
Overall mortality 14 4.0 (3.7—4.3) P = 0.002
Vascular events 11 2.8 (2.6—3.1) P < 0.001
Stroke/TIA 8 2.3 (2.0—2.7) P = 0.025
CHD 8 2.4 (2.1—2.7) P < 0.001
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Cigure 1 Meta-analysis of four trials showing the predictive v
eath) in patients with acute stroke.
e performed by a suitably trained nurse or health care
rofessional.
A reduced ABI has been shown to identify patients at risk
or cardiovascular events (Table 1). Patients with stroke or
ransient ischemic attack often had PAD. However, it is still
nclear whether PAD is also a good predictor for future cere-
rovascular disease. A recent meta-analysis demonstrated a
ooled multivariate adjusted relative risk of 1.35 (95% con-
dence interval, CI 1.10—1.65) for stroke in patients with an
BI < 0.9 [15].
Meves et al. [16] analyzed the association between
AD, either symptomatic or asymptomatic (deﬁned as an
BI < 0.9), and the future stroke risk in 6880 patients from
he German Epidemiological Trial on Ankle—Brachial Index
getABI), a large and prospective cohort study of a typical
rimary care sample of unselected elderly patients. During
he 5-year follow-up period, 183 patients had a stroke. In
atients with PAD (n = 1429) compared to those without PAD
n = 5392), the incidence of all stroke types, with the excep-
ion of hemorrhagic stroke, was about doubled (for fatal
troke tripled). The corresponding adjusted hazard ratios
ere 1.6 (95% CI 1.1—2.2) for total stroke, 1.7 (95% CI
.2—2.5) for ischemic stroke, 0.7 (95% CI 0.2—2.2) for hem-
rrhagic stroke, 2.5 (95% CI 1.2—5.2) for fatal stroke and
.4 (95% CI 0.9—2.1) for nonfatal stroke. Lower ABI cate-
ories were associated with higher stroke rates. Besides high
•
•of low ABI (<0.9) for new cardiovascular events (stroke, MI or
ge, previous stroke and diabetes mellitus, PAD was a signif-
cant independent predictor for ischemic stroke. The stroke
isk was similar in patients with symptomatic (n = 593) as
ompared to asymptomatic (n = 836) PAD.
Interestingly, recent studies that analyzed the prognos-
ic impact of low ABI values (<0.9) on stroke recurrence
nd cardiovascular events in acute stroke patients revealed
omparable results (Fig. 1). Purroy et al. [17] observed an
ncreased stroke recurrence rate (32.1 vs. 13.6%, p < 0.001)
nd more vascular events (50 vs. 70%, p < 0.001) in patients
ith low ABI values. Similar results were seen in the SCALA
rial [18] that examined 852 patients from 85 neurologi-
al stroke units throughout Germany as well as the PATHOS
tudy [19] from Italy with 755 acute stroke patients. Busch
t al. [20] described an increased risk for stroke, myocar-
ial infarction or death in acute stroke patients with a low
BI < 0.9 (relative risk 2.2; 95% CI 1.1—4.5).
onclusionAn ABI < 0.9 is an independent predictor of stroke recur-
rence in acute stroke.
The detection of PAD deﬁned as an ABI < 0.9 identiﬁes
high-risk patients for further vascular events; the vascular
nd?
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risk including stroke is clearly increased even in subjects
with asymptomatic PAD.
• Elderly patients in the primary care setting should be
screened for (asymptomatic) PAD to enable consequent
treatment of modiﬁable cardiovascular risk factors to
reduce the risk of ischemic stroke and other vascular
events; however, whether this screening is cost-effective
remains to be established.
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